Book Ceruloplasmin Test in Khammam

The Ceruloplasmin test is a blood test that measures the level of ceruloplasmin, the primary copper-carrying protein in the blood, produced by the liver and responsible for transporting approximately 65 to 90 percent of all copper circulating in the plasma. Ceruloplasmin is an alpha-2 glycoprotein with ferroxidase enzymatic activity, meaning it plays a dual role in both copper transport and iron metabolism by oxidising ferrous iron to ferric iron, facilitating its incorporation into transferrin for safe systemic transport. This makes ceruloplasmin a biochemical bridge between copper and iron metabolism, and its deficiency therefore has consequences for both mineral homeostasis pathways simultaneously. The clinical significance of the ceruloplasmin test lies primarily in its role in the diagnosis of Wilson's disease, a rare but serious autosomal recessive disorder of copper metabolism caused by mutations in the ATP7B gene, which encodes a copper-transporting ATPase expressed predominantly in the liver. In Wilson's disease, impaired hepatic copper excretion into bile leads to progressive copper accumulation first in the liver causing hepatitis and cirrhosis, then in the brain causing neurological and psychiatric manifestations, and in the cornea producing the pathognomonic Kayser-Fleischer rings visible on slit-lamp examination. Low ceruloplasmin is a hallmark laboratory finding in the majority of Wilson's disease patients, though it must be interpreted alongside urinary copper, serum copper, liver copper content, and genetic testing for complete diagnostic certainty. In India, Wilson's disease, though classified as a rare disease, is encountered more frequently than in Western populations due to the higher prevalence of consanguineous marriages in certain communities, and early diagnosis is critical because Wilson's disease is entirely treatable with copper chelation therapy if identified before irreversible organ damage occurs. The test is performed on a small blood sample drawn from a vein and completed in under five minutes.

Doctors prescribe a Ceruloplasmin test in the following situations: Diagnosing Wilson's disease in young patients presenting with unexplained chronic liver disease, acute liver failure, neurological symptoms including tremors, dysarthria, dystonia, and behavioural changes, or psychiatric manifestations where low ceruloplasmin alongside elevated urinary copper and Kayser-Fleischer rings forms the diagnostic triad that identifies this treatable copper metabolism disorder. Investigating unexplained liver disease in children, adolescents, and young adults where Wilson's disease must be excluded as a potentially reversible cause before attributing hepatic dysfunction to other aetiologies, as missing the diagnosis leads to progressive irreversible liver and neurological damage that copper chelation could have prevented. Evaluating neuropsychiatric presentations in young adults with movement disorders, cognitive decline, personality change, and psychosis where Wilson's disease is an important differential diagnosis and ceruloplasmin measurement is a simple and accessible first-line investigation to screen for this condition before more invasive testing. Assessing copper deficiency states in patients with malabsorption syndromes, prolonged parenteral nutrition, excessive zinc supplementation, and bariatric surgery where low ceruloplasmin reflects systemic copper depletion causing anaemia, neutropenia, and neurological manifestations including myelopathy and peripheral neuropathy. Investigating aceruloplasminaemia, a rare genetic disorder of complete ceruloplasmin deficiency causing progressive iron accumulation in the brain and visceral organs, in patients with a combination of diabetes, retinal degeneration, and progressive neurological deterioration where the combination of absent ceruloplasmin and elevated serum ferritin suggests this diagnosis. Monitoring copper chelation therapy response in confirmed Wilson's disease patients where serial ceruloplasmin and urinary copper measurements track the effectiveness of treatment with penicillamine, trientine, or zinc acetate and guide dose adjustments to achieve safe and sustained copper depletion.

The Ceruloplasmin test measures the concentration of ceruloplasmin protein in the blood serum, expressed in milligrams per decilitre (mg/dL). The normal reference range for adults is 20 to 60 mg/dL, with values slightly higher in women, particularly during pregnancy and while taking oestrogen-containing oral contraceptives, as oestrogen stimulates hepatic ceruloplasmin synthesis. Normal (20 to 60 mg/dL) A result within the normal range indicates adequate ceruloplasmin production and copper transport capacity. In the context of Wilson's disease evaluation, a normal ceruloplasmin does not entirely exclude the diagnosis as approximately 5 to 15 percent of Wilson's disease patients, particularly those presenting with acute liver failure, may have normal or even elevated ceruloplasmin due to its behaviour as an acute phase reactant. Clinical correlation with urinary copper and liver investigations remains essential. Low Ceruloplasmin (Below 20 mg/dL) A low ceruloplasmin result is the most clinically significant finding and is the hallmark laboratory abnormality in Wilson's disease, present in approximately 85 percent of patients. Low ceruloplasmin may also be seen in copper deficiency, aceruloplasminaemia, nephrotic syndrome with protein loss, severe malnutrition, and advanced liver failure from any cause where synthetic function is globally impaired. Clinical context and additional copper studies are essential for distinguishing Wilson's disease from other causes of low ceruloplasmin. Elevated Ceruloplasmin (Above 60 mg/dL) An elevated ceruloplasmin is a non-specific finding reflecting its role as an acute phase reactant, with levels rising in response to inflammation, infection, malignancy, pregnancy, oestrogen therapy, and rheumatoid arthritis. While elevated ceruloplasmin effectively argues against Wilson's disease in most clinical contexts, it does not provide specific diagnostic information about the underlying cause of the elevation and must be interpreted alongside the full clinical picture.

No fasting is strictly required for the Ceruloplasmin test as food intake does not significantly affect ceruloplasmin concentrations. However since this test is frequently ordered alongside serum copper, urinary copper, liver function tests, and full blood count as part of a copper metabolism panel, fasting for 8 hours before collection is generally advisable to ensure accuracy of all co-ordered investigations and to standardise conditions across the panel. Inform your doctor about oral contraceptive use and oestrogen-containing hormone replacement therapy before the test, as oestrogens significantly elevate ceruloplasmin levels and can mask a mildly low result that would otherwise point toward Wilson's disease or copper deficiency. Where clinically feasible, a temporary pause in oestrogen therapy before testing may be considered by your physician to improve diagnostic accuracy. Inform your doctor about recent acute illnesses, infections, inflammatory conditions, and pregnancy, as ceruloplasmin is an acute phase reactant and these states cause non-specific elevation that can falsely normalise a result that would otherwise be diagnostically low. If you are being tested as part of a Wilson's disease evaluation, a 24-hour urinary copper collection is typically ordered alongside the serum ceruloplasmin and should be discussed with your doctor to ensure both tests are conducted under appropriate conditions. Staying well hydrated before the blood draw facilitates easier venous access and a smooth collection experience.

If you are booking through the SecondMedic platform the Ceruloplasmin test price in Khammam can cost you around Rs. 847. You may also consider booking a comprehensive copper metabolism panel that includes Ceruloplasmin alongside serum copper, 24-hour urinary copper, and liver function tests for a complete evaluation of copper metabolism disorders at a bundled price on SecondMedic.

SecondMedic offers convenient home sample collection for the Ceruloplasmin test in Khammam, making it easy to get tested without visiting a diagnostic centre. Home collection is available free of charge for orders above Rs. 300. A trained phlebotomist will visit your preferred address between 7 AM and 10 PM, seven days a week, including Sundays and public holidays. Your blood sample is processed at NABL-accredited partner laboratories, and your report is delivered within 24 hours directly to your WhatsApp and email.